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This study was undertaken to investigate the toxicological profile of a methanolic extract of Garcinia pedunculata fruit in rats by
conducting hematological, biochemical, and histopathological examinations. Long Evans rats were divided into four groups, each
with 6 animals, and were treated with three oral doses (250, 500, and 1000mg/kg) once daily for 21 days. The extract did not cause
significant changes in body and relative organweight, percentwater content, or hematological parameters at any administered doses.
However, a significant dose-dependent positive effect in serum lipid profile and all atherogenic indices including the cardiac risk
ratio, Castelli’s risk index-2, and the atherogenic coefficient were observed. Significant increases in the levels of iron and decreases in
serum alkaline phosphatase, alanine transaminase, and lactate dehydrogenase activities and the levels of serum glucose were noted
when the extract was administered at the highest dose (1000mg/kg). Histopathological examination of the target tissues further
confirmed that the extract was safe and had no observed toxicological features. Our study indicates that G. pedunculata fruit is
nontoxic, has the potential to be effective against atherosclerosis, and may be used as a hepatoprotectant. The fruit extract is also
beneficial to those with iron deficiency and hyperglycemia.
1. Introduction
Garcinia pedunculata (G. pedunculata) is a medicinal indige-
nous plant belonging to the Clusiaceae family. The fruit of G.
pedunculata is commonly known as “Taikor” in Bangladesh
and “Amlavetasa” in India [1]. The mature G. pedunculata
fruit is greenish yellow and is consumed as a vegetable; it is
also used as an ingredient in cooking different types of meat
and chicken [2]. This fruit extract is reported to possess a
variety of pharmacological benefits including antioxidant [3,
4], antimicrobial [5], anti-inflammatory [6], hepatoprotective
[1], and cardioprotective properties [7].
G. pedunculata has been traditionally used for cooking
and as an antiscorbutic, an astringent, a cardiotonic, and
an emollient. It is also utilized in the treatment of chronic
catarrh, asthma, cough, bronchitis, dysentery, digestion, and
fever [8]. However, the specific chemical compounds respon-
sible for these beneficial effects have not yet been identified.
Recently, the phytochemical composition of G. pedunculata
was investigated andG. pedunculatawas estimated to contain
moisture 88.20%, protein 0.50%, 𝛽 carotene 45.00mg/100 g,
vitamins (thiamine 0.03, riboflavin 0.02, and ascorbic acid
142.83mg/100 g, resp.), minerals (sodium 1.80, potassium
106.00, calcium 18.00, magnesium 23.00, iron 0.08, zinc
0.15, copper 0.12, and phosphorus 17.00mg/100 g), phenolics
(19.45mg gallic acid/100 g), and flavonoids (18.33mg rutin/g)
[2].The dried fruit rinds and pericarp ofG. pedunculata have
been reported to contain some benzophenones, pedenculol,
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hydroxy citric acid, garcinol, and cambogin [9], some of
which are strong antioxidants. Previous research suggested
that benzophenones and garcinol showed hepatocyte pro-
tective and anti-inflammatory effects, respectively [10, 11].
Hence, it is presumed that these chemical compounds and
other phytochemicals, as well as polyphenols, present in G.
pedunculata may contribute to the beneficial pharmacologi-
cal effects. Despite its diverse uses, there are no studies on the
safety and toxicology profile of the fruit.Therefore, the aim of
this study is to assess the possible toxic effects of amethanolic
extract of G. pedunculata in a rat model using biochemical,
hematological, and histopathological parameters.
2. Materials and Methods
2.1. Chemicals and Reagents. Methanol was purchased from
Sigma (Sigma-Aldrich, St. Louis, MO, USA). All chemicals
and reagents used in this experiment were of analytical grade.
2.2. Fruit Sample Collection. Mature and freshG. pedunculata
fruits were randomly collected from the Sylhet district of
Bangladesh in March, 2015. The fruit was authenticated
by Professor Nuhu Alam from the Department of Botany,
Jahangirnagar University, where a voucher specimen was
deposited. Following collection, the fruits were cleaned with
sterile water in a laminar blower to remove any possible con-
tamination and were subsequently stored in the refrigerator
(4∘C) for a day before further processing.
2.3. Extract Preparation. The methanol extract of G. pedun-
culata was prepared according to a method as described
by Uddin et al. [12] with slight modifications. Briefly, the
cleaned freshmatured fruitswere thoroughly rinsedwith cold
sterile water.The edible portion was carefully removed.Then,
the fruits were cut into small pieces using a stainless steel
blade and were dried under sunlight. When the samples were
free of moisture and had a crunchy appearance, they were
separately crushed into fine powders using a blender (Jaipan
Commando, Mumbai, India). Crushed samples (100 g) were
mixed with a sufficient amount of pure methanol (400mL)
and were kept in a shaker (IKA400i, Germany) at 150 rpm
and 30∘C for 72 h. The extracts were filtered using Whatman
No. 1 filter paper, and the solvent was removed using a rotary
evaporator (R-215, BUCHI, Switzerland) under a reduced
pressure (100 psi) at a controlled temperature (40∘C) to
recover the soluble components of the samples. Then, the
concentrated (33.51%) extract (mass of extract × 100/mass of
powder) was preserved at −20∘C for later use.
2.4. Experimental Animals. Long Evans rats at the ages of
16–18 weeks (150–250 g) of both sexes were obtained from
the Department of Pharmacology, Bangladesh University of
Health Sciences (BUHS), Dhaka, Bangladesh. The animals
were maintained in an animal housing facility in the Depart-
ment of Biochemistry and Molecular Biology, Jahangirnagar
University, at a constant temperature of 22 ± 3∘C and with
humidity ranging from 44% to 56%. The rats were housed in
clean plastic cages and received a natural 12 h day-night cycle.
Animals were provided with the standard rodent pellet diet
and water ad libitum. All of the studies were conducted in
accordance with the internationally established principles of
the US guidelines (NIH publication #85-23, revised in 1985).
The experimental protocol was approved by the Biosafety,
Biosecurity & Ethical Committee of Jahangirnagar Univer-
sity.
2.5. Experimental Design. The rats were acclimatized one
week prior to the experiment andwere randomly divided into
four groups of six animals; each group contained an equal
number of each sex.
Group A (Normal Control). Animals received normal diets
and drinking water ad libitum.
Group B (Treatment 1). Animals received G. pedunculata
extract (250mg/kg) dissolved in saline water by oral gavaging
for 21 days. (All animals received standard laboratory diet and
drinking water ad libitum.)
Group C (Treatment 2). Animals received G. pedunculata
extract (500mg/kg) dissolved in saline water by oral gavaging
for 21 days. (All animals received standard laboratory diet and
drinking water ad libitum.)
Group D (Treatment 3). Animals received G. pedunculata
extract (1000mg/kg) dissolved in saline water by oral gav-
aging for 21 days. (All animals received standard laboratory
diet and drinking water ad libitum.)
During the experimental study, the body weights of the
rats were recorded weekly. The animals were also monitored
for behavioral changes in their feeding and drinking habits
to detect any sign of abnormalities. At the end of the experi-
mental period, all animals were fasted for 15 h.Then, all of the
rats were anaesthetized by intraperitoneal administration of
a ketamine hydrochloride injection (500mg/kg) [13]. Blood
samples (5mL)were collected from the inferior vena cava and
were divided into two portions.The first was transferred into
tubes containing ethylene diamine tetra acetic acid (EDTA)
for hematological analysis, and the remaining blood was
placed into plain tubes for serum separation for subsequent
biochemical analysis. Selected organs were immediately
removed, weighed, and stored in tubes containing formalin
(10%) for histopathological examination.
2.6. Measurements of Body Weight, Relative Organ Weight
Profile, and Percentage of Water Content. Immediately after
sacrifice, the following tissues were excised and weighed:
heart, kidney, lung, liver, spleen, caecum, pancreas, brain,
testes, thymus, caput, Cowper’s gland, stomach, ovary, and
Fallopian tubes. The relative organ weight was calculated by
dividing the individual weight of each organ with the final
body weight of each rat according to following formula [14]:
relative organ weight (%) = wet organ weight/body weight ×
100.
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The percentage of water content was estimated from the
respective weight of each wet organ by subtracting the dry
weight of each organ [15].
2.7. Hematological Parameters. Hematological parameters
such as white blood cells (WBCs), neutrophils, lymphocytes,
monocytes, eosinophils, red blood cells (RBCs), hemoglo-
bin (HGB), hematocrit (HCT), mean corpuscular vol-
ume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), platelets
(PLT), red cell distribution width-standard deviation (RDW-
SD), red cell distribution width-coefficient of variation
(RDW-CV), platelets distribution width (PDW), mean plate-
lets volume (MPV), platelets larger cell ratio (P-LCR), and
procalcitonin (PCT) were analyzed using an automated
hematology analyzer (8000i, Sysmex, Japan) for the control
and treatment groups.
2.8. Biochemical Parameters. The collected sera were used for
analysis of biochemical parameters [sodium (Na+), potas-
sium (K+), chloride (Cl−), magnesium (Mg2+), phosphate
(PO3+) ions, calcium (Ca2+), total protein (TP), albumin
(ALB), albumin/globulin (A/G) ratio, high-density lipopro-
tein cholesterol (HDL-C), total cholesterol (TC), triglyc-
eride (TG), alanine transaminase (ALT), aspartate transam-
inase (AST), alkaline phosphatase (ALP), lactate dehydroge-
nase (LDH), 𝛾-glutamyltransferase (GGT), creatinine (Crea),
urea, uric acid (UA), iron (Fe), total iron binding capacity
(TIBC), glucose (GLU), amylase, and lipase]. The measure-
ments were determined following standard procedures using
an automated chemistry analyzer (Dimension EXL with LM
Integrated Chemistry System, Siemens Medical Solutions
Inc., USA). On the other hand, low-density lipoprotein
cholesterol (LDL-C) levels in the serumwere estimated based
on the following Friedewald formula [16]:
LDL-C = TC −HDL-C − TG5 . (1)
Atherogenic indices such as cardiac risk ratio (CRR),
atherogenic coefficient (AC), atherogenic index of plasma
(AIP), and Castelli’s risk index-2 (CRI-2) were calculated
using the following formulas:
CRR = TC
HDL-C
, (2)
AC = (TC −HDL-C)
HDL-C
, (3)
AIP = log( TG
HDL-C
) , (4)
CRI-2 = LDL-C
HDL-C
. (5)
See [17–20] for equations (2), (3), (4), and (5), respectively.
2.9. Histopathological Examination. For histopathological
examination, the liver, kidney, lung, intestine, brain, stomach,
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Figure 1: Effects of G. pedunculata fruit extract on body weight (g)
gain. Results are expressed as the mean ± SD (𝑛 = 6).
pancreas, and heart were fixed in 10% neutral formalin. The
fixed organs tissues were then embedded in paraffin. The
paraffinized tissue specimens were cut into 5𝜇m thick slices
and were stained with hematoxylin and eosin (H&E) for
histopathological observation using a previously established
procedure [21]. Photomicrographs were captured using a
normal spectra fluorescent microscope (Olympus DP 72) at
6100x magnification with an attached digital camera (Olym-
pus, Tokyo, Japan).
2.10. Statistical Analysis. All results were presented as the
mean values ± standard deviation (SD). Data were analyzed
using SPSS (Statistical Packages for Social Science, version
16.0, IBM Corporation, New York, USA) and Microsoft
Excel 2007 (Redmond, Washington, USA). All of the data of
treatment groups were compared to the control group using
one-wayANOVA followed byDunnett’smultiple comparison
tests. A 𝑝 value of <0.05 was considered as statistically
significant.
3. Results
3.1. Effects of G. pedunculata Fruit Extract on Body Weight,
Relative Organ Weight, and Percent Water Content of Rat’s
Organs. No significant change in body weight gain was
observed among the control and treatment groups. Dur-
ing the experimental period, the body weight gradually
increased, but the change was not significantly different from
the first to the third week (Figure 1). There was also no
significant difference between the control and treatment
groups for both the relative organ weight and the percentage
of the water content of the organs (Tables 1 and 2).
3.2. Effects of G. pedunculata Fruit Extract on Hematological
Parameters. There was no significant difference among the
control and treatments groups in terms of the hematological
parameters (Table 3).
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Table 1: Effects of G. pedunculata fruit extract on the relative organ weight.
Organ Control G. pedunculata treatment group
250mg/kg 500mg/kg 1000mg/kg
Heart 0.280 ± 0.01 0.283 ± 0.04 0.299 ± 0.02 0.261 ± 0.01
Kidney 0.589 ± 0.03 0.617 ± 0.14 0.663 ± 0.07 0.623 ± 0.03
Lung 0.548 ± 0.08 0.527 ± 0.11 0.596 ± 0.10 0.547 ± 0.02
Liver 3.060 ± 0.29 3.110 ± 0.54 3.080 ± 0.24 3.073 ± 0.28
Spleen 0.352 ± 0.05 0.344 ± 0.03 0.355 ± 0.05 0.353 ± 0.03
Caecum 0.352 ± 0.05 0.367 ± 0.03 0.357 ± 0.05 0.366 ± 0.06
Pancreas 0.165 ± 0.03 0.174 ± 0.03 0.140 ± 0.05 0.189 ± 0.01
Brain 0.811 ± 0.08 0.780 ± 0.01 0.791 ± 0.04 0.787 ± 0.08
Testes 0.072 ± 0.01 0.076 ± 0.01 0.079 ± 0.01 0.073 ± 0.01
Thymus 0.183 ± 0.01 0.204 ± 0.01 0.178 ± 0.02 0.133 ± 0.05
Caput 0.356 ± 0.09 0.371 ± 0.20 0.357 ± 0.12 0.344 ± 0.12
CPG 0.131 ± 0.01 0.137 ± 0.01 0.136 ± 0.01 0.137 ± 0.03
Stomach 0.620 ± 0.13 0.642 ± 0.04 0.625 ± 0.08 0.622 ± 0.09
Ovary 0.065 ± 0.02 0.070 ± 0.01 0.084 ± 0.00 0.063 ± 0.01
FT 0.263 ± 0.00 0.257 ± 0.05 0.252 ± 0.01 0.262 ± 0.03
Results are expressed as the mean ± SD (𝑛 = 6).
Here, CPG: Cowper’s gland; FT: Fallopian tubes.
Table 2: Effects of G. pedunculata fruit extract on the percentage of water content of different organs.
Organ Control G. pedunculata treatment group
250mg/kg 500mg/kg 1000mg/kg
Heart 75.52 ± 1.55 77.76 ± 4.03 77.71 ± 2.00 75.86 ± 0.42
Kidney 71.82 ± 8.85 74.83 ± 2.03 70.73 ± 4.92 73.07 ± 2.35
Lung 76.33 ± 4.24 76.13 ± 2.96 77.51 ± 1.03 76.76 ± 1.45
Liver 65.38 ± 3.39 67.69 ± 3.29 65.18 ± 4.31 68.56 ± 1.61
Spleen 75.60 ± 1.74 75.10 ± 0.67 75.06 ± 0.71 74.51 ± 1.82
Caecum 72.34 ± 3.48 68.45 ± 2.52 72.69 ± 2.38 73.56 ± 4.29
Pancreas 66.60 ± 5.56 64.36 ± 1.91 69.48 ± 6.94 69.51 ± 5.67
Brain 55.52 ± 2.05 55.44 ± 3.47 59.44 ± 4.14 59.66 ± 5.63
Testes 78.58 ± 5.18 79.38 ± 4.69 77.14 ± 5.13 73.48 ± 9.90
Thymus 71.75 ± 2.17 72.53 ± 2.19 72.74 ± 2.97 74.54 ± 5.33
Caput 73.20 ± 3.39 73.77 ± 3.10 74.84 ± 4.08 74.74 ± 3.96
CPG 74.82 ± 4.04 77.13 ± 5.31 74.74 ± 3.50 72.07 ± 5.91
Stomach 75.33 ± 0.96 77.42 ± 2.50 75.83 ± 1.15 75.13 ± 0.26
Ovary 58.96 ± 3.34 56.69 ± 4.64 61.00 ± 8.48 62.21 ± 2.02
FT 78.74 ± 0.03 74.10 ± 11.96 77.71 ± 6.68 75.51 ± 4.51
Results are expressed as the mean ± SD (𝑛 = 6).
3.3. Effects of G. pedunculata Fruit Extract on the Serum
Biochemical Parameters. Theeffects of oralG. pedunculata on
liver function are presented in Figure 2 and Table 4.The fruit
extract exerted no adverse effect on the parameters of liver
function, such as ALT, AST, ALP, GGT, and LDH activities
and TB levels. Moreover, ALT, ALP, and GGT levels were sig-
nificantly decreased when the highest dose (1000mg/kg) was
administered. Nevertheless, TP, ALB, GLB, and A/G, which
are important biomarkers for liver function, remained
unchanged at the three dose levels (Table 4).
The effects of G. pedunculata on renal function were
investigated by measuring the serum urea, uric acid, and
creatinine levels and the major electrolytes such as Na+,
K+, Cl−, Mg2+, PO3+, and Ca2+ (Table 5). The methanolic
extract of G. pedunculata did not significantly affect the renal
function biomarkers or alter the body homeostasis markers
(electrolytes) when administered at all doses.
Lipid profiles (TC, TG, HDL-C, and LDL-C) and athero-
genic indices (CRR, AC, AIP, and CRI-2) are reliable markers
for cardiovascular diseases. The methanolic extract of G.
pedunculata significantly reduced the serum TG and LDL-C
levels (Figure 3) and all atherogenic indices (Table 6) when
administered at the three different doses. Rats given the
1000mg/kg dose had significantly reduced TC levels and
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Table 3: Effects of G. pedunculata fruit extract on the hematological parameters of whole blood.
Hematological parameters Control G. pedunculata treatment group
250mg/kg 500mg/kg 1000mg/kg
WBC (×109/L) 5.32 ± 0.70 5.67 ± 1.16 5.71 ± 0.73 5.76 ± 1.70
Neutrophils (%) 34.55 ± 1.56 34.65 ± 6.77 36.87 ± 20.92 34.07 ± 9.92
Lymphocytes (%) 60.90 ± 5.63 61.05 ± 4.70 61.20 ± 21.12 61.8 ± 12.14
Monocytes (%) 1.27 ± 0.17 1.15 ± 0.12 1.15 ± 0.12 1.35 ± 0.31
Eosinophils (%) 1.17 ± 0.53 1.22 ± 0.58 1.05 ± 0.49 0.90 ± 0.21
RBC (×1012/L) 7.43 ± 0.69 7.83 ± 0.53 7.38 ± 0.90 7.48 ± 1.39
HGB (g/dL) 14.00 ± 2.32 15.10 ± 0.76 14.00 ± 1.57 14.07 ± 2.43
HCT (%) 41.65 ± 3.07 41.55 ± 1.98 40.85 ± 3.58 40.92 ± 0.83
MCV (fL) 52.72 ± 1.51 52.82 ± 2.59 52.00 ± 1.80 52.83 ± 0.89
MCH (pg) 18.92 ± 0.37 19.12 ± 0.38 19.25 ± 0.42 19.12 ± 0.45
MCHC (g/dL) 36.3 ± 0.63 36.92 ± 1.47 36.92 ± 0.38 36.20 ± 0.43
PLT (×109/L) 877 ± 51.26 827 ± 53.67 875.75 ± 52.88 889.25 ± 69.19
RDW-SD (fL) 32.92 ± 3.03 32.60 ± 1.73 31.4 ± 1.34 32.37 ± 2.26
RDW-CV (%) 20.32 ± 2.88 20.65 ± 1.11 20.31 ± 1.42 20.52 ± 2.00
PDW (fL) 10.42 ± 0.32 10.07 ± 0.83 9.52 ± 0.35 9.90 ± 0.74
MPV (fL) 9.30 ± 0.18 9.05 ± 0.44 8.77 ± 0.26 8.95 ± 0.36
P-LCR (%) 19.62 ± 1.38 17.92 ± 3.83 15.37 ± 2.42 16.57 ± 2.71
PCT (%) 0.75 ± 0.12 0.74 ± 0.07 0.72 ± 0.18 0.76 ± 0.04
Results are expressed as the mean ± SD (𝑛 = 6).
Here, HGB: hemoglobin, HCT: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin
concentration, PLT: platelets, RDW-SD: red cell distribution width-standard deviation, RDW-CV: red cell distribution width-coefficient of variation, PDW-
CV: platelets distribution width, MPV: mean platelets volume, P-LCR: platelets larger cell ratio, and PCT: procalcitonin.
C
on
ce
nt
ra
tio
n 
(U
/L
)
∗
∗
∗
∗
AST ALP GGT LDHALT
0
50
100
150
200
250
Control
250mg/kg
500 mg/kg
1000 mg/kg
Figure 2: Effects of G. pedunculata fruit extract on the serum
hepatic marker enzymes. Results are expressed as the mean ± SD
(𝑛 = 6). ∗ denotes a significant difference when compared to the
control group.
increased HDL-C levels when compared to those of the other
two treatment groups. However, there was no significant
difference in the HDL-C levels observed for the other two
treatment groups.
The methanolic extract of G. pedunculata fruit had a
positive effect on the iron profile, as treatment with the
1000mg/kg dose increased these levels significantly. The
other two treatment groups (250mg/kg and 500mg/kg)
showed nonsignificant increases in iron levels. In addition,
all three doses nonsignificantly decreased the TIBC level
(Figure 4).
The fruit extract affected neither the pancreatic function
(Table 7) nor the blood glucose level (Figure 5). The extract
also did not significantly change the serumamylase and lipase
levels.The extract had a positive effect on the glycemic status,
as rats administered with the highest dose (1000mg/kg) had
significantly reduced blood glucose levels.
3.4. Histopathological Examination. The histopathological
investigation of the liver, kidney, lung, intestine, brain,
stomach, pancreas, and heart did not show any remark-
able morphological and pathological changes following the
administration of G. pedunculata methanolic extract at the
three doses for 21 days when compared with the control
(Figure 6).
4. Discussion
To our knowledge, this study is the first to show that G.
pedunculata extract has the potential to cause significant
increases in the levels of iron and high-density lipoprotein
cholesterol while decreasing the serum activities of alkaline
phosphatase, alanine transaminase, lactate dehydrogenase,
and the serum glucose level when administered at a high dose
(1000mg/kg). Because a gradual increase in the body weight
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Table 4: Effects of G. pedunculata fruit extract on the serum total bilirubin (TB), total protein (TP), and albumin (ALB) levels and the
albumin/globulin (A/G) ratio.
Biochemical parameters Control G. pedunculata treatment group
250mg/kg 500mg/kg 1000mg/kg
TB (mg/dL) 0.15 ± 0.05 0.14 ± 0.05 0.15 ± 0.05 0.13 ± 0.04
TP (g/L) 56.00 ± 4.83 54.8 ± 4.20 53.50 ± 1.29 54.5 ± 1.73
ALB (g/L) 34.50 ± 2.64 33.00 ± 3.16 32.75 ± 2.21 31.75 ± 1.70
A/G 1.61 ± 0.10 1.51 ± 0.10 1.58 ± 0.21 1.41 ± 0.24
Results are expressed as the mean ± SD (𝑛 = 6).
Table 5: Effects of G. pedunculata fruit extract on the serum renal markers.
Biochemical parameters Control G. pedunculata treatment group
250mg/kg 500mg/kg 1000mg/kg
Urea (mmol/L) 5.45 ± 0.54 5.32 ± 0.55 6.05 ± 0.12 4.93 ± 0.70
UA (mmol/L) 45.50 ± 4.79 48.20 ± 2.58 44.50 ± 6.75 45.00 ± 3.55
Crea (mmol/L) 39.75 ± 3.09 37.20 ± 4.81 42.00 ± 1.82 42.25 ± 1.25
Na+ (mmol/L) 141.00 ± 2.58 139.60 ± 6.18 139.50 ± 3.10 142.00 ± 4.39
K+ (mmol/L) 4.12 ± 0.15 4.12 ± 0.50 4.10 ± 0.33 4.02 ± 0.17
Cl− (mmol/L) 101.50 ± 2.64 100.8 ± 3.76 100.75 ± 1.70 99.75 ± 1.70
PO3+ (mmol/L) 2.30 ± 0.29 2.34 ± 0.26 2.25 ± 0.35 2.17 ± 0.23
Ca2+ (mmol/L) 2.12 ± 0.22 2.14 ± 0.27 2.30 ± 0.14 2.27 ± 0.05
Mg2+ (mmol/L) 0.82 ± 0.12 0.92 ± 0.13 0.80 ± 0.08 0.85 ± 0.05
Results are expressed as the mean ± SD (𝑛 = 6).
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Figure 3: Effects of G. pedunculata fruit extract on lipid profiles.
Results are expressed as the mean ± SD (𝑛 = 6). ∗ denotes
a significant difference when compared to the control group as
determined using one-way ANOVA followed by Dunnett’s multiple
comparison tests.
was observed in both the treatment and the control groups,
it is also concluded that the extract has no negative effects on
the normal growth of rats.
Toxicological agents or substances cause abnormal
metabolic reactions in the body that may affect major
organs such as the liver, heart, lung, spleen, brain, kidney,
and reproductive organs including the testes, caput, and
Cowper’s gland in males and the ovary and Fallopian tubes
in females [22]. Therefore, the body weight, relative organ
weight profile, and percentage water content are important
parameters for the pathological and physiological status of
both human and animals. Relative organ weight profiles are
essential for interpreting the effect of a drug and reduce the
variability of the data and increase the chances of detecting
treatment effects. Loss of organ weight is a common
parameter in the assessment of a drug’s toxicity [23, 24]. In
the present study, no significant changes in relative organ
weight were observed between the three treatment groups
and the control group, indicating that the methanolic extract
of G. pedunculata did not have any toxic effects on the rats.
The percentage of water content is another important
factor in assessing the toxic effects of a drug in animals.
In this study, we also found no significant changes in the
percent water content in the different organs of rats after G.
pedunculata administration, indicating that the fruit has no
toxic effect on normal body homeostasis.
Analysis of the hematological parameters is very impor-
tant in assessing the toxic effects of any foreign compound or
plant extract, as well as in determining the physiological and
pathological status of the body [25]. Various hematological
tests were performed in this study for the diagnosis and
monitoring of various diseases and conditions, including
anemia, leukemia, reactions to inflammation and infections,
hydration and dehydration states, and polycythemia, as well
as hemolysis. Our study indicated that the administration of
G. pedunculata fruit causes no abnormal changes in any of
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Table 6: Effects of G. pedunculata fruit extract on the atherogenic indices.
Biochemical parameters Control G. pedunculata treatment group
250mg/kg 500mg/kg 1000mg/kg
CRR 1.81 ± 0.07 1.58 ± 0.05∗ 1.47 ± 0.08∗ 1.42 ± 0.11∗
ACC 0.81 ± 0.07 0.58 ± 0.05∗ 0.47 ± 0.08∗ 0.42 ± 0.11∗
AIP 0.36 ± 0.02 0.23 ± 0.03∗ 0.18 ± 0.06∗ 0.16 ± 0.10∗
CRI-2 0.34 ± 0.07 0.23 ± 0.04∗ 0.16 ± 0.04∗ 0.12 ± 0.05∗
Values are expressed as the mean ± SD (𝑛 = 6).
∗ denotes a significant difference when compared to the control group.
Table 7: Effects of G. pedunculata fruit extract on pancreatic function.
Biochemical parameters Control G. pedunculata treatment group
250mg/kg 500mg/kg 1000mg/kg
Amylase (U/L) 730.50 ± 30.96 753.60 ± 49.57 734.50 ± 20.55 725.75 ± 84.45
Lipase (U/L) 32.25 ± 3.40 29.40 ± 1.67 29.50 ± 1.73 29.00 ± 0.81
Results are expressed as the mean ± SD (𝑛 = 6).
the hematological parameters investigated with no observed
anemia, leukemia, inflammation, infections, polycythemia,
and/or thalassemia.
WBCs of all types (neutrophils, lymphocytes, eosino-
phils, monocytes, and basophils) play important role in the
immune system to combat infections. Excess produc-
tion of leukocytes is a biomarker for inflammation and
stress disorders [26]. Red blood cell and hematocrit counts
as well as the hemoglobin concentration are essential to
determine the effect of chemical substances on the hemato-
poietic system [27]. Previous studies reported that the levels
of hemoglobin and hematocrit increase with dehydration,
renal cell carcinoma, hypoxia, pulmonary fibrosis, and/or
polycythemia vera and decrease with anemia, bleeding,
bone marrow failure, hemolysis, leukemia, malnutrition, and
overhydration where the body is intoxicated by foreign toxic
substances [28, 29]. Moreover, RBC indices (MCV, MCH,
andMCHC) are important biomarkers for the early diagnosis
of anemia. Platelets indices (MPV and PDW) and P-LCR
are also key markers for the diagnosis of atherosclerosis,
thromboembolic and ischemic heart disease, which increases
during platelet activation [30–32]. Nevertheless, the admin-
istration of G. pedunculata to the rats yielded no significant
changes in these investigated parameters, indicating that it is
nontoxic and does not affect the blood composition.
The liver is the largest and most vital organ in animals, as
it is involved in the detoxification and elimination of foreign
substances [33]. Increased activities of ALT, AST, GGT, ALP,
and LDH in the serum are utilized to determine hepatic
dysfunction and are directly implicated in the extent of
hepatic damage and toxicity [33, 34]. ALT is a hepatocyte
cytoplasmic enzyme, and ALP is mostly synthesized by liver.
Elevation of ALT and ALP activities in the serum indicates
liver dysfunction or,more specifically, cholestasis [35, 36]. On
the other hand, increased activities of AST and LDH in the
serum indicate not only myocardial but also hepatocellular
injuries [37]. Our study revealed that rats treated with
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Figure 4: Effects of G. pedunculata fruit extract on iron profiles.
Results are expressed as the mean ± SD (𝑛 = 6). ∗ denotes a
significant difference when compared to the control group.
G. pedunculata had almost unchanged serum activities of
ALT, ALP, AST, GGT, and LDH, except for the rats that
received the highest (1000mg/kg) dose. Because the animals
treated with G. pedunculata extract at 1000mg/kg showed
significantly decreased levels of the marker enzymes in the
serum compared to those of the control, it is plausible
that the extract can restrict the leakage of hepatic enzymes
into the circulation (as also confirmed by the preservation
of cells based on the histopathological findings) via some
unknown mechanism. Our findings are in agreement with
a previous study where G. pedunculata was shown to con-
fer some hepatoprotective effects [1] when administered at
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Figure 5: Effects of G. pedunculata fruit extract on blood glucose
levels. Values are expressed as the mean ± SD (𝑛 = 6). ∗ denotes a
significant difference when compared to the control group.
400mg/kg. Furthermore, the microscopic examinations of
rat liver treated with 1000mg/kg of the fruit extract lacked
any cellular necrosis or centrilobular degenerative changes,
infiltration of any inflammatory cells, and changes in cell
sizes or architecture, further confirming the safety of the fruit
extract shown by the biochemical findings.
The TB, TP, ALB, GLB, and albumin levels and the
globulin (A/G) ratio are also important biomarkers for liver
toxicity [37]. The rise in the TB level is an important
clinical indicator for the severity of necrosis, whereas its
accumulation is themeasure of the binding, conjugation, and
excretory capacity of the hepatic cells [38]. In addition, serum
TP and albumin levels can provide information about the
severity of the necrosis and the capacity for protein synthesis
[34]. In this study, there were no significant differences in the
levels of TB, TP, ALB, GLB, or albumin or the globulin (A/G)
ratio among the treatment groups. These findings indicate
that the extracts of the G. pedunculata fruit contain no toxic
constituents, thus allowing normal hepatic excretory and
synthetic functions.
Our research also investigated the effects of G. peduncu-
lata on the kidney by measuring the serum level of urea, uric
acid, and creatinine, which are specific indicators and highly
sensitive biomarkers of kidney function. An incremental
change in thesemolecules tends to be observed whenmarked
damage to functional nephrons occurs [39, 40]. In our
study, no significant changes were observed in these renal
biomarkers with the administration of all doses, indicating
that the fruit extract is not toxic to the kidneys.These findings
were further confirmed by the relative organ weight, the
percentwater content, and the histopathological observations
of the kidney tissues.
Electrolytes are minerals found in the blood and other
bodily fluids that carry an electrical charge and are essential
for the maintenance of bodily functions including heartbeat,
nerve transmission, muscle contraction, energy production,
pH balance, and fluid balance [41]. The kidneys play an
important role in keeping the electrolyte balance constant,
even while bodily changes occur. Significantly imbalanced
electrolytes may contribute to nervous system disorders,
muscle spasms, weakness, convulsion, and changes in blood
pressure [42, 43]. In our study, the measured electrolytes,
including Na+, K+, Cl−, Mg2+, PO3+, and Ca2+, remained
almost unchanged in all of the treatment groups even when
G. pedunculata was administered at the highest dose of
1000mg/kg. This finding indicates that the fruit extract of G.
pedunculata does not alter the homeostasis of the body.
The lipid profile is often quantitatively measured to diag-
nose primary and secondary hyperlipoproteinemia, triglyc-
eridemia, liver obstruction, fatty liver disease [39, 44], and
pancreatitis [45]. High plasma triglycerides and cholesterol
levels are linked to atherosclerosis and predispose an indi-
vidual to cardiovascular disease. They also contribute to
hypertension, obesity, and diabetesmellitus [39, 46, 47]. LDL-
C (also called “bad cholesterol”) can accumulate in the walls
of arteries to cause cardiovascular diseases. Therefore, it is
considered a major risk factor in the occurrence of coronary
artery disease [48, 49], hypertension, and obesity [50]. In this
work, the fruit extract showed dose-dependent reductions in
the serum levels of TG, TC, and LDL-C and an incremental
change in the HDL-C levels. Rats treated with 1000mg/kg of
extract had significantly reduced serum TC levels and sig-
nificantly increased HDL-C levels, whereas there were non-
significant increases in HDL-C levels for the other two doses.
This finding confirms that G. pedunculata fruit may have
a protective effect against cardiovascular-related disorders.
The presence of high HDL-C levels in the plasma tends
to exert a protective effect by reversing cholesterol trans-
port because HDL-C scavenges excess cholesterol from the
peripheral tissues of the body [39].
Atherogenic indices are derived from the lipid profiles
to predict the risk of cardiovascular disease. When these
indices increase, the risk of cardiovascular disease increases
[47, 51, 52].The administration of fruit extract to rats at three
doses significantly reduced all of the atherogenic indices.
Therefore, these findings provide strong support in favor of
the cardioprotective effect of the fruit.
When interpreted together, the serum iron and TIBC
can help to confirm the diagnosis of iron deficiency; low
iron levels and high TIBC are associated with iron deficiency
anemia or hemochromatosis [53]. In addition, a high level
of iron is also associated with liver and kidney disease and
is also a risk factor for cancer. Low TIBC is associated
with liver and ischemic heart disease [54–56]. Our findings
suggest that G. pedunculata significantly ameliorated iron
levels when administered at the highest dose. This finding
further supports the use ofG. pedunculata fruit for preventive
effects against iron deficiency-related disorders.
Serum amylase and lipase activities are twomajor indica-
tors of pancreatic function. According to the guidelines from
theAmericanCollege of Gastroenterology (ACG), diagnostic
values of serum amylase and/or lipase in excess of three to
five times upper limit of normal are characteristic of acute
pancreatitis and are usually not reported to occur in other
conditions [39, 57]. However, research shows that serum
lipase activity is a more reliable diagnostic marker for acute
pancreatitis [58, 59]. In our study, no significant effects on
pancreatic function, amylase and lipase levels, were observed
in the treated rats.
Blood glucose level measurements are used for the early
diagnosis of diabetes mellitus [60]. Traditional medicinal
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Figure 6: Histopathological photomicrographs of the control and treatment groups (1000mg/kg) (6100x magnification, scale bar: 20 𝜇m).
Nomorphological or pathological changes were observed between the control andG. pedunculata administered groups. Here, C: control; Gp:
G. pedunculata (1000mg/kg) treatment group.
plants are widely used for the prevention of diabetes mel-
litus based on their ability to restore pancreatic function
by increasing insulin secretion, inhibiting intestinal glu-
cose absorption, reducing oxidative stress, and facilitating
metabolites in insulin dependent processes [61]. The extract
of the G. pedunculata fruit has a positive effect on the
glycemic status. We observed that the rats administered with
1000mg/kg dose had significantly reduced blood glucose
levels, indicating that G. pedunculata fruit may be effective
against hyperglycemia. The histomicrograph of the pancreas
and spleen further confirmed the biochemical findings. The
investigated possible effects of the fruit extract on some other
vital organs including the brain, lung, and stomach revealed
no adverse sign of damage to these tissues, as confirmed
by histopathological examination of the microphotograph.
The overall study of G. pedunculata fruit suggests that the
consumption of this fruit at the investigated dose levels is
nontoxic, safe, and beneficial to some extent.
5. Conclusion
Thebiochemicalmeasurements of liver function, lipid profile,
atherogenic indices, and blood glucose levels indicate that
G. pedunculata fruit has significant hepatoprotective, car-
dioprotective, and hypoglycemic activities and ameliorates
iron levels. The extract is also safe when used at up to
1000mg/kg; it showed no undesirable effects on body weight,
relative organ weight, or the percent water content of vital
organs. In addition, no major changes were observed in
any other hematological, biochemical, and histopathological
parameters.
Disclosure
Sudip Paul and Md. Yousuf Ali are joint first authors.
Competing Interests
The authors declare that there is no conflict of interests.
Acknowledgments
This research is supported by the TWAS Research Grant no.
14-385 RG/PH/AS C-UNESCO FR: 3240283438.
References
[1] R. Mundugaru, M. C. Varadharajan, and R. Basavaiah, “Hep-
atoprotective activity of fruit extract of garcinia pedunculata,”
Bangladesh Journal of Pharmacology, vol. 9, no. 4, pp. 483–487,
2014.
[2] M. Z. Islam, M. M. Hoque, S. M. Asif-Ul-Alam, and K.
Monalisa, “Chemical composition, antioxidant capacities and
storage stability of Citrusmacroptera andGarcinia pedunculata
fruits,” Emirates Journal of Food and Agriculture, vol. 27, no. 3,
pp. 275–282, 2015.
[3] M. Z. Islam, M. M. Hoque, S. M. Asif-Ul-Alam, and K.
Monalisa, “Chemical composition, antioxidant capacities and
storage stability of Citrus macroptera and Garcinia pedunculata
fruits,” Emirates Journal of Food & Agriculture, vol. 27, no. 3, pp.
275–282, 2015.
[4] T. Mudoi, D. C. Deka, and R. Devi, “In vitro antioxidant activity
of Garcinia pedunculata, an indigenous fruit of North Eastern
(NE) region of India,” International Journal of PharmTech
Research, vol. 4, no. 1, pp. 334–342, 2012.
[5] P. S. Negi, G. K. Jayaprakasha, and B. S. Jena, “Antibacterial
activity of the extracts from the fruit rinds of Garcinia cowa
and Garcinia pedunculata against food borne pathogens and
spoilage bacteria,” LWT—Food Science and Technology, vol. 41,
no. 10, pp. 1857–1861, 2008.
[6] R. Mundugaru, F. Joy, R. Shrinidhi, L. Das, and R. B. Sud-
hakara, “Anti inflammatory activity of aqueous extract of fruits
of garcinia pedunculata in experimental animals,” American
Journal of PharmTech Research, vol. 4, no. 3, 2014.
[7] R. Mundugaru, P. Udaykumar, S. Senthilkumar, and S. Bhat,
“Cardioprotective activity of fruit of garcinia pedunculata on
isoprenaline-induced myocardial infarction in rat,” Bangladesh
Journal of Pharmacology, vol. 11, no. 1, pp. 231–235, 2016.
[8] R. Kagyung, P. R. Gajurel, P. Rethy, and B. Singh, “Ethnomedic-
inal plants used for gastro-intestinal diseases by Adi tribes
of Dehang-Debang Biosphere Reserve in Arunachal Pradesh,”
10 Evidence-Based Complementary and Alternative Medicine
Indian Journal of Traditional Knowledge, vol. 9, no. 3, pp. 496–
501, 2010.
[9] A. Sahu, B. Das, and A. Chatterjee, “Polyisoprenylated ben-
zophenones from Garcinia pedunculata,” Phytochemistry, vol.
28, no. 4, pp. 1233–1235, 1989.
[10] M. Mitcheva, M. Kondeva, V. Vitcheva, P. Nedialkov, and G.
Kitanov, “Effect of benzophenones from hypericum annulatum
on carbon tetrachloride-induced toxicity in freshly isolated rat
hepatocytes,” Redox Report: Communications in Free Radical
Research, vol. 11, no. 1, pp. 3–8, 2006.
[11] W.-L. Hung, C.-M. Liu, C.-S. Lai, C.-T. Ho, and M.-H.
Pan, “Inhibitory effect of garcinol against 12-O-tetradecan-
oylphorbol 13-acetate-induced skin inflammation and tumori-
genesis in mice,” Journal of Functional Foods, vol. 18, pp. 432–
444, 2015.
[12] N. Uddin, R. Hasan,M.Hasan et al., “Assessment of toxic effects
of the methanol extract of citrus macroptera montr. fruit via
biochemical and hematological evaluation in female sprague-
dawley rats,” PLOS ONE, vol. 9, no. 11, Article ID e111101, 2014.
[13] D. Ringler and L. Dabich, “Hematology and clinical biochem-
istry,”The Laboratory Rat, vol. 1, pp. 105–121, 1979.
[14] Z. Liu, C. Li, M. Li, D. Li, and K. Liu, “The subchronic toxicity
of hydroxysafflor yellow A of 90 days repeatedly intraperitoneal
injections in rats,” Toxicology, vol. 203, no. 1–3, pp. 139–143,
2004.
[15] J. M. Peters and E. M. Boyd, “Organ weights and water levels of
the rat following reduced food intake,” Journal of Nutrition, vol.
90, no. 4, pp. 354–360, 1966.
[16] W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation
of the concentration of low-density lipoprotein cholesterol in
plasma, without use of the preparative ultracentrifuge,” Clinical
Chemistry, vol. 18, no. 6, pp. 499–502, 1972.
[17] D. M. Martirosyan, L. A. Miroshnichenko, S. N. Kulakova, A.
V. Pogojeva, and V. I. Zoloedov, “Amaranth oil application for
coronary heart disease and hypertension,” Lipids in Health and
Disease, vol. 6, article no. 1, 2007.
[18] A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden,
“Relationship between serum lipoprotein ratios and insulin
resistance in obesity,” Clinical Chemistry, vol. 50, no. 12, pp.
2316–2322, 2004.
[19] M. Dobia´sˇova´, “Atherogenic index of plasma [log(triglycerides/
HDL-cholesterol)]: theoretical and practical implications,”
Clinical Chemistry, vol. 50, no. 7, pp. 1113–1115, 2004.
[20] W. P. Castelli, R. D. Abbott, and P. M. McNamara, “Summary
estimates of cholesterol used to predict coronary heart disease,”
Circulation, vol. 67, no. 4, pp. 730–734, 1983.
[21] H.M.Carleton,Histological Technique, OxfordUniversity Press,
London, UK, 1980.
[22] E. Dybing, J. Doe, J. Groten et al., “Hazard characterisation of
chemicals in food and diet: dose response, mechanisms and
extrapolation issues,” Food and Chemical Toxicology, vol. 40, no.
2-3, pp. 237–282, 2002.
[23] R. S. Sellers, D.Morton, B.Michael et al., “Society of Toxicologic
Pathology position paper: organ weight recommendations for
toxicology studies,” Toxicologic Pathology, vol. 35, no. 5, pp. 751–
755, 2007.
[24] J. M. Peters and E. M. Boyd, “Organ weights and water levels of
the rat following reduced food intake,”The Journal of Nutrition,
vol. 90, no. 4, pp. 354–360, 1966.
[25] H. Olson, G. Betton, D. Robinson et al., “Concordance of the
toxicity of pharmaceuticals in humans and in animals,” Regula-
tory Toxicology and Pharmacology, vol. 32, no. 1, pp. 56–67, 2000.
[26] R. Ross, “Atherosclerosis—an inflammatory disease,” The New
England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999.
[27] M.M.Wintrobe and J. P. Greer,Wintrobe’s Clinical Hematology,
Lippincott Williams &Wilkins, 2009.
[28] H. K.Walker,W.D.Hall, and J.W.Hurst,ClinicalMethods, 1990.
[29] N. W. Tietz, Clinical Guide to Laboratory Tests, WB Saunders
Co, Philadelphia, Pa, USA, 1995.
[30] M. Gawaz, H. Langer, and A. E. May, “Platelets in inflammation
and atherogenesis,” Journal of Clinical Investigation, vol. 115, no.
12, pp. 3378–3384, 2005.
[31] E. Vagdatli, E. Gounari, E. Lazaridou, E. Katsibourlia, F.
Tsikopoulou, and I. Labrianou, “Platelet distribution width: a
simple, practical and specific marker of activation of coagula-
tion,” Hippokratia, vol. 14, no. 1, pp. 28–32, 2010.
[32] A. Ihara, T. Kawamoto, K. Matsumoto, S. Shouno, T. Morimoto,
and Y. Noma, “Relationship between hemostatic factors and
the platelet index in patients with ischemic heart disease,”
Pathophysiology of Haemostasis and Thrombosis, vol. 35, no. 5,
pp. 388–391, 2006.
[33] S. Paul, M. A. Islam, E. M. Tanvir et al., “Satkara (Citrus
macroptera) fruit protects against acetaminophen-induced hep-
atorenal toxicity in rats,” Evidence-based Complementary and
Alternative Medicine, vol. 2016, Article ID 9470954, 11 pages,
2016.
[34] E. M. Tanvir, R. Afroz, M. A. Z. Chowdhury et al., “Honey
has a protective effect against chlorpyrifos-induced toxicity on
lipid peroxidation, diagnostic markers and hepatic histoarchi-
tecture,” European Journal of Integrative Medicine, vol. 7, no. 5,
pp. 525–533, 2015.
[35] A. Singh, T. K. Bhat, and O. P. Sharma, “Clinical biochemistry
of hepatotoxicity,” Journal of Clinical Toxicology, S4, article 001,
2011.
[36] S. K. Ramaiah, “A toxicologist guide to the diagnostic interpre-
tation of hepatic biochemical parameters,” Food and Chemical
Toxicology, vol. 45, no. 9, pp. 1551–1557, 2007.
[37] P. L. Wolf, “Biochemical diagnosis of liver disease,” Indian
Journal of Clinical Biochemistry, vol. 14, no. 1, pp. 59–90, 1999.
[38] E. M. Tanvir, R. Afroz, M. A. Z. Chowdhury et al., “A model of
chlorpyrifos distribution and its biochemical effects on the liver
and kidneys of rats,”Human& Experimental Toxicology, vol. 35,
no. 9, pp. 991–1004, 2016.
[39] S. Paul,M. S.Hossen, E.M. Tanvir et al., “Antioxidant properties
of citrus macroptera fruit and its in vivo effects on the liver,
kidney and pancreas in wistar rats,” International Journal of
Pharmacology, vol. 11, no. 8, pp. 899–909, 2015.
[40] N. Lameire, W. Van Biesen, and R. Vanholder, “Acute renal
failure,” Lancet, vol. 365, no. 9457, pp. 417–430, 2005.
[41] L. Baer, S. R. Platman, and R. R. Fieve, “The role of electrolytes
in affective disorders: sodium, potassium, and lithium ions,”
Archives of General Psychiatry, vol. 22, no. 2, pp. 108–113, 1970.
[42] J. A. Yu-Yahiro, “Electrolytes and their relationship to normal
and abnormal muscle function,” Orthopaedic Nursing, vol. 13,
no. 5, pp. 38–40, 1994.
[43] W. M. Kirkendall, W. E. Connor, F. Abboud, S. P. Rastogi, T. A.
Anderson, andM. Fry, “The effect of dietary sodium chloride on
blood pressure, body fluids, electrolytes, renal function, and
serum lipids of normotensive man,” The Journal of Laboratory
and Clinical Medicine, vol. 87, no. 3, pp. 411–434, 1976.
[44] C. A. Matteoni, Z. M. Younossi, T. Gramlich, N. Boparai,
Yao Chang Liu, and A. J. McCullough, “Nonalcoholic fatty
liver disease: a spectrum of clinical and pathological severity,”
Gastroenterology, vol. 116, no. 6, pp. 1413–1419, 1999.
Evidence-Based Complementary and Alternative Medicine 11
[45] J. D. Brunzell andH. G. Schrott, “The interaction of familial and
secondary causes of hypertriglyceridemia: role in pancreatitis,”
Journal of Clinical Lipidology, vol. 6, no. 5, pp. 409–412, 2012.
[46] G. X. Shen, “Lipid disorders in diabetes mellitus and current
management,”Current Pharmaceutical Analysis, vol. 3, no. 1, pp.
17–24, 2007.
[47] O. Ademuyiwa, R. N. Ugbaja, F. Idumebor, and O. Adebawo,
“Plasma lipid profiles and risk of cardiovascular disease in
occupational lead exposure in Abeokuta, Nigeria,” Lipids in
Health and Disease, vol. 4, no. 1, article 19, 2005.
[48] W. P. Castelli, R. J. Garrison, P. W. F. Wilson, R. D. Abbott, S.
Kalousdian, and W. B. Kannel, “Incidence of coronary heart
disease and lipoprotein cholesterol levels: the framingham
study,” JAMA, vol. 256, no. 20, pp. 2835–2838, 1986.
[49] S. M. Grundy, J. I. Cleeman, C. N. B. Merz et al., “Implications
of recent clinical trials for the national cholesterol education
program adult treatment panel III guidelines,” Journal of the
AmericanCollege of Cardiology, vol. 44, no. 3, pp. 720–732, 2004.
[50] J. Shepherd, “Identifying patients at risk for coronary heart
disease: treatment implications,” European Heart Journal, vol.
19, no. 12, pp. 1776–1783, 1998.
[51] S. Bhardwaj, J. Bhattacharjee, M. Bhatnagar, and S. Tyagi,
“Atherogenic index of plasma, castelli risk index and athero-
genic coefficient-new parameters in assessing cardiovascular
risk,” International Journal of Pharmacy and Biological Sciences,
vol. 3, no. 3, pp. 359–364, 2013.
[52] M. A. Beydoun, H. A. Beydoun, G. A. Dore, M. T. Fanelli-
Kuczmarski, M. K. Evans, and A. B. Zonderman, “Total serum
cholesterol, atherogenic indices and their longitudinal associa-
tion with depressive symptoms amongUS adults,” Translational
Psychiatry, vol. 5, no. 3, article e518, 2015.
[53] N. C. Andrews, “Disorders of iron metabolism,” New England
Journal of Medicine, vol. 341, no. 26, pp. 1986–1995, 1999.
[54] M. K. Magnusson, N. Sigfusson, H. Sigvaldason, G. M. Johan-
nesson, S. Magnusson, and G.Thorgeirsson, “Low iron-binding
capacity as a risk factor for myocardial infarction,” Circulation,
vol. 89, no. 1, pp. 102–108, 1994.
[55] R. G. Stevens, D. Y. Jones, M. S. Micozzi, and P. R. Taylor,
“Body iron stores and the risk of cancer,” New England Journal
of Medicine, vol. 319, no. 16, pp. 1047–1052, 1988.
[56] R. Agarwal, N. Vasavada, N. G. Sachs, and S. Chase, “Oxidative
stress and renal injury with intravenous iron in patients with
chronic kidney disease,” Kidney International, vol. 65, no. 6, pp.
2279–2289, 2004.
[57] S. Tenner, J. Baillie, J. Dewitt, and S. S. Vege, “American college
of gastroenterology guideline: management of acute pancreati-
tis,” American Journal of Gastroenterology, vol. 108, no. 9, pp.
1400–1415, 2013.
[58] P.-A. Clavien, S. Burgan, and A. R. Moossa, “Serum enzymes
and other laboratory tests in acute pancreatitis,” British Journal
of Surgery, vol. 76, no. 12, pp. 1234–1243, 1989.
[59] M. Ventrucci, R. Pezzilli, L. Gullo, L. Plate´, G. Sprovieri, and L.
Barbara, “Role of serum pancreatic enzyme assays in diagnosis
of pancreatic disease,” Digestive Diseases and Sciences, vol. 34,
no. 1, pp. 39–45, 1989.
[60] K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis
and classification of diabetesmellitus and its complications. Part
1: diagnosis and classification of diabetes mellitus. Provisional
report of aWHO consultation,”Diabetic Medicine, vol. 15, no. 7,
pp. 539–553, 1998.
[61] N. Malviya, S. Jain, and S. Malviya, “Antidiabetic potential of
medicinal plants,” Acta Poloniae Pharmaceutica, vol. 67, no. 2,
pp. 113–118, 2010.
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
